Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism TOP1 inhibitors(DNA topoisomerase I inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC21H16F2N2O4 |
InChIKeyLFQCJSBXBZRMTN-OAQYLSRUSA-N |
CAS Registry220997-97-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Small Cell Lung Cancer | Phase 2 | FR | - | |
Small Cell Lung Cancer | Phase 2 | GB | - | |
Small Cell Lung Cancer | Phase 2 | US | - | |
Small Cell Lung Cancer | Phase 2 | - | - | |
Small Cell Lung Cancer | Phase 2 | FR | - | |
Small Cell Lung Cancer | Phase 2 | - | - | |
Small Cell Lung Cancer | Phase 2 | NL | - | |
Small Cell Lung Cancer | Phase 2 | GB | - | |
Small Cell Lung Cancer | Phase 2 | US | - | |
Small Cell Lung Cancer | Preclinical | NL | - |
Phase 1 | - | 17 | (clulrvplqf) = implemzily pkmvjeogkv (raiyixkhfj ) View more | - | 15 Jul 2004 |